申请人:Vernalis Research Limited
公开号:US06433175B1
公开(公告)日:2002-08-13
A chemical compound of formula (I), wherein n is 1, 2 or 3; R1 and R2 are independently selected from hydrogen and alkyl; R3 is alkyl; R4 to R7 are independently selected from hydrogen, halogen, hydroxy, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, alkylsulfoxyl, alkylsulfonyl, arylsulfoxyl, arylsulfonyl, amino, monoalkylamino, dialkylamino, nitro, cyano, carboxaldehyde, alkylcarbonyl, arylcarbonyl, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonylamino, aminocarbonyloxy, monoalkylaminocarbonyloxy, dialkylaminocarbonyloxy, monoalkylaminocarbonylamino and dialkylaminocarbonylamino, or R5 and R6 together form a carbocyclic or heterocyclic ring, and pharmaceutically acceptable salts and prodrugs thereof, and the use thereof in therapy, particularly for the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders, diabetes insipidus, and sleep apnea, and particularly for the treatment of obesity
化学式为(I)的化合物,其中n为1,2或3;R1和R2分别选择氢和烷基;R3为烷基;R4至R7分别选择氢、卤素、羟基、烷基、芳基、烷氧基、芳氧基、烷硫基、芳硫基、烷基亚氧基、烷基磺酰氧基、芳基磺酰氧基、芳基磺酰氧基、氨基、单烷基氨基、双烷基氨基、硝基、氰基、羧醛基、烷基羰基、芳基羰基、氨基羰基、单烷基氨基羰基、双烷基氨基羰基、烷氧羰基氨基、氨基羧酸酯、单烷基氨基羧酸酯、双烷基氨基羧酸酯、单烷基氨基羧酸氧酯、双烷基氨基羧酸氧酯,或R5和R6共同形成一个碳环或杂环,以及其药学上可接受的盐和前药,以及在治疗中的使用,特别是用于治疗中枢神经系统疾病;中枢神经系统损伤;心血管疾病;胃肠道疾病、尿崩症和睡眠呼吸暂停症,特别是用于治疗肥胖症。